{'fraction_non_alphanumeric': 0.02871410736579276, 'fraction_numerical': 0.011235955056179775, 'mean_word_length': 5.31496062992126, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
According to the Article “Cytokine Expression in Human Osteoblasts After Antiseptic Treatment: A Comparative Study between Polyhexanide and Chlorhexidine” by Röhner E. et al., Journal of Investigative Surgery, 28, 1–7, 2015

Treatment and handling of infections or special risk situations are without any doubt challenging questions in different fields of medical treatment. Hence, contributions to a better, easier and safer therapy are highly welcome. Following thus, the article published by Röhner and colleagues [1] is an important input to clarify the use of antiseptic substances in bone infection. We, the authors of this letter to the editor, appreciate the information; however, we do feel the need to challenge some aspects and especially the clinical interpretation of this in vitro study.